| Background: | This gene encodes an enzyme that removes the C(7-8) double bond in the B ring of sterols and catalyzes the conversion of 7-dehydrocholesterol to cholesterol. This gene is ubiquitously expressed and its transmembrane protein localizes to the endoplasmic reticulum membrane and nuclear outer membrane. Mutations in this gene cause Smith-Lemli-Opitz syndrome (SLOS); a syndrome that is metabolically characterized by reduced serum cholesterol levels and elevated serum 7-dehydrocholesterol levels and phenotypically characterized by mental retardation, facial dysmorphism, syndactyly of second and third toes, and holoprosencephaly in severe cases to minimal physical abnormalities and near-normal intelligence in mild cases. Alternative splicing results in multiple transcript variants that encode the same protein. | 
| Applications: | ELISA, IHC | 
| Name of antibody: | DHCR7 | 
| Immunogen: | Fusion protein of human DHCR7 | 
| Full name: | 7-dehydrocholesterol reductase | 
| Synonyms: | SLOS | 
| SwissProt: | Q9UBM7 | 
| ELISA Recommended dilution: | 1000-2000 | 
| IHC positive control: | Human colon cancer and human thyroid cancer | 
| IHC Recommend dilution: | 25-100 | 
	
	 
 购物车
购物车 帮助
帮助
 021-54845833/15800441009
021-54845833/15800441009 
              